Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Goh

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Cancer|July 6, 2017
The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET)Kathryn M Field, Pramit M Phal, Greg Fitt, et al.
Asia-Pacific Journal of Clinical Oncology|November 9, 2017
Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trialKathryn M Field, Greg Fitt, Mark A Rosenthal, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Cancer|July 6, 2017
The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET)Kathryn M Field, Pramit M Phal, Greg Fitt, et al.
Asia-Pacific Journal of Clinical Oncology|November 9, 2017
Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trialKathryn M Field, Greg Fitt, Mark A Rosenthal, et al.
Pageof 2